256 related articles for article (PubMed ID: 28725600)
1. Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?
Lopez DS; Advani S; Tsilidis KK; Wang R; Canfield S
Transl Androl Urol; 2017 Jun; 6(3):566-579. PubMed ID: 28725600
[TBL] [Abstract][Full Text] [Related]
2. Testosterone replacement therapy and the heart: friend, foe or bystander?
Lopez DS; Canfield S; Wang R
Transl Androl Urol; 2016 Dec; 5(6):898-908. PubMed ID: 28078222
[TBL] [Abstract][Full Text] [Related]
3. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database.
Lopez DS; Huang D; Tsilidis KK; Khera M; Williams SB; Urban RJ; Panagiotou OA; Kuo YF; Baillargeon J; Farias A; Krause T
Clin Endocrinol (Oxf); 2019 Dec; 91(6):885-891. PubMed ID: 31498469
[TBL] [Abstract][Full Text] [Related]
4. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk.
Khera M; Miner M; Jaffe J; Pastuszak AW
J Sex Med; 2021 Jan; 18(1):83-98. PubMed ID: 33317996
[TBL] [Abstract][Full Text] [Related]
5. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer.
Lopez DS; Huang D; Tsilidis KK; Canfield S; Khera M; Baillargeon JG; Kuo YF; Peek MK; Platz EA; Markides K
Cancer Causes Control; 2021 Sep; 32(9):965-976. PubMed ID: 34041642
[TBL] [Abstract][Full Text] [Related]
6. Testosterone therapy in prostate cancer: is it still a controversy?
Bart AS; Van Hoof A; Badre-Hume R; Selvarajah J; Robillard K; Albala DM
Curr Opin Urol; 2022 Nov; 32(6):598-606. PubMed ID: 36081393
[TBL] [Abstract][Full Text] [Related]
7. Safety of testosterone therapy in men with prostate cancer.
Morgentaler A; Caliber M
Expert Opin Drug Saf; 2019 Nov; 18(11):1065-1076. PubMed ID: 31495240
[No Abstract] [Full Text] [Related]
8. Is testosterone a friend or a foe of the prostate?
Jannini EA; Gravina GL; Morgentaler A; Morales A; Incrocci L; Hellstrom WJ
J Sex Med; 2011 Apr; 8(4):946-55. PubMed ID: 21457469
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores.
Corona G; Rastrelli G; Morgentaler A; Sforza A; Mannucci E; Maggi M
Eur Urol; 2017 Dec; 72(6):1000-1011. PubMed ID: 28434676
[TBL] [Abstract][Full Text] [Related]
10. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
[TBL] [Abstract][Full Text] [Related]
11. Controversies in Testosterone Therapy.
Twitchell DK; Pastuszak AW; Khera M
Sex Med Rev; 2021 Jan; 9(1):149-159. PubMed ID: 33309270
[TBL] [Abstract][Full Text] [Related]
12. Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007-2015.
Lopez DS; Kim H; Polychronopoulou E; Taha S; Tsilidis KK; Villasante-Tezanos A; Peek MK; Gilani S; Khera M; Baillargeon J; Kuo YF; Canfield S
Cancer Epidemiol; 2022 Aug; 79():102172. PubMed ID: 35523034
[TBL] [Abstract][Full Text] [Related]
13. Controversies with testosterone therapy.
Khera M
Can J Urol; 2020 Aug; 27(S3):20-23. PubMed ID: 32875998
[TBL] [Abstract][Full Text] [Related]
14. Risk of Testosterone Flare in the Era of the Saturation Model: One More Historical Myth.
Krakowsky Y; Morgentaler A
Eur Urol Focus; 2019 Jan; 5(1):81-89. PubMed ID: 28753828
[TBL] [Abstract][Full Text] [Related]
15. Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis.
Boyle P; Koechlin A; Bota M; d'Onofrio A; Zaridze DG; Perrin P; Fitzpatrick J; Burnett AL; Boniol M
BJU Int; 2016 Nov; 118(5):731-741. PubMed ID: 26779889
[TBL] [Abstract][Full Text] [Related]
16. The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy.
Klap J; Schmid M; Loughlin KR
J Urol; 2015 Feb; 193(2):403-13. PubMed ID: 25260832
[TBL] [Abstract][Full Text] [Related]
17. Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials.
van Die MD; Bone KM; Williams SG; Pirotta MV
BJU Int; 2014 May; 113(5b):E119-30. PubMed ID: 24053483
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. The Role of Testosterone Therapy in the Setting of Prostate Cancer.
Rodriguez KM; Pastuszak AW; Khera M
Curr Urol Rep; 2018 Jun; 19(8):67. PubMed ID: 29961247
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
